Rang	Name	Position
1	Dr. Clay B. Siegall Ph.D.	Chairman, President & CEO
2	Mr. Max Rosett	Chief Financial Officer
3	Dr. Robert J. Lechleider M.D.	Chief Medical Officer
4	Dr. Philip Tsai	Chief Technical Officer
5	Dr. Jack Higgins Ph.D.	Chief Scientific Officer
6	Ms. Sandra G. Stoneman Esq., J.D.	Chief Legal Officer, General Counsel & Corporate Secretary
7	Mr. Kinney Horn	Chief Business Officer
8	Mr. Roee Shahar	Executive Vice President of Commercial

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	FMR Inc	14,94%	0,42 Mrd. USD
2	T. Rowe Price Investment Management,Inc.	14,41%	0,40 Mrd. USD
3	BlackRock Inc	7,19%	0,20 Mrd. USD
4	State Street Corp	4,75%	0,13 Mrd. USD
5	Wellington Management Company LLP	4,59%	0,13 Mrd. USD
6	Redmile Group, LLC	4,32%	0,12 Mrd. USD
7	PRIMECAP Management Company	4,03%	0,11 Mrd. USD
8	Vanguard Capital Management, LLC	3,90%	0,11 Mrd. USD
9	Driehaus Capital Management LLC	3,61%	0,10 Mrd. USD
10	Enavate Sciences GP, LLC	3,18%	0,09 Mrd. USD
11	T. Rowe Price Associates, Inc.	2,52%	0,07 Mrd. USD
12	Morgan Stanley - Brokerage Accounts	2,50%	0,07 Mrd. USD
13	JPMorgan Chase & Co	2,45%	0,07 Mrd. USD
14	Geode Capital Management, LLC	2,25%	0,06 Mrd. USD
15	SILVERARC CAPITAL MANAGEMENT, LLC	1,63%	0,05 Mrd. USD
16	Sofinnova Ventures	1,50%	0,04 Mrd. USD
17	Woodline Partners LP	1,39%	0,04 Mrd. USD
18	Marshall Wace Asset Management Ltd	1,30%	0,04 Mrd. USD
19	Principal Financial Group Inc	1,19%	0,03 Mrd. USD
20	Readystate Asset Management LP	1,15%	0,03 Mrd. USD